ARVN
NASDAQ · Pharmaceuticals
Arvinas Inc
$8.14
+0.40 (+5.17%)
Open$7.63
Previous Close$7.74
Day High$8.19
Day Low$7.63
52W High$14.51
52W Low$6.06
Volume—
Avg Volume737.1K
Market Cap494.88M
P/E Ratio—
EPS$-3.26
SectorPharmaceuticals
Analyst Ratings
Buy
26 analysts
Price Target
+713.5% upside
Current
$8.14
$8.14
Target
$66.22
$66.22
$44.47
$66.22 avg
$75.30
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 241.49M | 191.72M | 233.97M |
| Net Income | -74,303,364 | -53,090,685 | 39.13M |
| Profit Margin | -30.8% | -29.2% | 16.7% |
| EBITDA | -106,219,384 | -80,111,475 | 67.61M |
| Free Cash Flow | — | — | 28.90M |
| Rev Growth | +26.0% | +26.0% | +1.6% |
| Debt/Equity | 0.00 | 0.00 | 0.23 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |